Certara (HAM:700) Preferred Dividends : €0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Certara Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Certara's preferred dividends for the three months ended in Sep. 2024 was €0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Sep. 2024 was €0.0 Mil.

Certara Preferred Dividends Historical Data

The historical data trend for Certara's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Certara Preferred Dividends Chart

Certara Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Get a 7-Day Free Trial

Certara Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Certara Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Certara (HAM:700) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Certara Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Certara Inc (HAM:700) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

CERT:USA

Address

100 Overlook Center, Suite 101, Princeton, NJ, USA, 08540

Website

https://www.certara.com

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Certara Headlines

No Headlines